Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Image Credit: PharmaVoice Announcement Eli Lilly and Company inaugurates the new Lilly Gateway Labs (LGL) site in San Diego, California. The company is extending its reach of shared innovation hub...
Image Credit: Femasys Inc. Announcement Femasys Inc., a known biomedical innovator making accessible fertility and non-surgical permanent birth control, and has been cost-effective to the women's ...
Image Credit: Oxford University Innovation Announcement Pepgen Inc., a leading clinical-level biotechnology company advancing the next generation future of oligonucleotide therapies with a motive ...
Announcement Eli Lilly and Company intends to build a new manufacturing facility worth $6.5 billion at the Generation Park in Houston, Texas. This intensification of the future synthetic medicine act...
Image Credit: AInvest Announcement Patient Square Capital, an affiliate of an investment firm, acquired healthcare firm Premier with a finalized deal value of approximately $2.6 billion. Patient S...
Image Credits: MSN Announcement Due to AbbVie’s $1.2 billion acquisition of Gilgamesh Pharmaceuticals' known depression drug, the psychedelic therapeutics revived from lykos rejection last...
Announcement The Sunflower Therapeutics, a known public-oriented corporation transitioning global access to protein manufacturing potential for different applications, showed the receipt of its fir...
Image Credits: Via Ritzau Announcement The Crown Bioscience, a leading contract research organization (CRO) headquartered in the United States and a significant part of JSR Life Sciences and Japan...
Image Credits: Guru Focus Announcement Bionano Genomics, Inc., fixed the pricing of $10 million of a public offering of a total of 5,000,000 shares of the company’s common stock, serie...
Announcement Avidity biosciences inc, a leading biopharmaceutical company dedicated to provide a new class of RNA therapeutics known as antibody oligonucleotide conjugates (AOCs) have closed its la...
Speak with a healthcare analyst about your research, consulting, or platform needs.